Skip to main
RGLS
RGLS logo

Regulus Therapeutics (RGLS) Market Capitalization Overview

Market Cap: $564.96M as of Jul 1, 2025

$564.96M
Past Month+$15.93M (2.90%)
As of Jul 1, 2025, Regulus Therapeutics (RGLS) has a market capitalization of $564.96M. Over the past 30 days, its market cap has increased by 2.77%, while in the last 12 months, it has increased by 445.9%.

Market capitalization represents the total value of Regulus Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Regulus Therapeutics (RGLS) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Regulus Therapeutics (RGLS) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Regulus Therapeutics (RGLS) Market Cap History

DateMarket CapChange
Jul 1, 2025$564.96M+2.77%
Jun 2, 2025$549.72M+5.71%
May 1, 2025$520.02M+348.57%
Apr 1, 2025$115.93M+40.46%
Mar 3, 2025$82.54M+2.44%
Feb 3, 2025$80.57M-21.15%
Jan 2, 2025$102.19M-4.29%

Regulus Therapeutics (RGLS) End of Year Market Cap History

DateMarket CapChange
2025$564.96M+445.90%
2024$103.50M+299.81%
2023$25.89M+12.20%
2022$23.08M-49.82%
2021$45.99M-49.49%
2020$91.04M

FAQs About Regulus Therapeutics (RGLS) Market Cap

As of Jul 1, 2025, the market capitalization of Regulus Therapeutics (RGLS) is $564.96M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Regulus Therapeutics’s market capitalization has increased by 2.90%, changing from $549.03M to $564.96M as of Jul 1, 2025.

In the last 3 months, Regulus Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Regulus Therapeutics’s market capitalization increased from $25.89M in January to $103.50M in December, reflecting a 299.81% change.

In the past five years, Regulus Therapeutics (RGLS) has had a compound annual growth rate (CAGR) of 2.60% in market capitalization. This means its market cap has grown at an average rate of 2.60% per year.

Regulus Therapeutics (RGLS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.